Previous Close | 0.555 |
1-Year Change | -74.19% |
6-Months Change | 51.64% |
3-Months Change | 64.69% |
Moving Avg (50d) | 0.4853 |
Moving Avg (200d) | 0.6364 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 54.6M |
Beta (3-Years) | 1.52 |
Revenue Growth (ttm) | 26.09% |
Net Profit Margin (ttm) | -189.81% |
Return On Assets (ttm) | -63.89% |
EPS (ttm) | -3.07 |
PE Ratio (ttm) | -0.18 |
Dividend Yield | % |
Asset Description: | FibroGen, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-02-12 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
0.566 | 0.583 | 0.594 | 0.611 | 0.638 | 0.666 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |